Meadow Creek Wealth Advisors LLC Buys Shares of 1,754 UnitedHealth Group Incorporated (NYSE:UNH)

Meadow Creek Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, Holdings Channel reports. The fund purchased 1,754 shares of the healthcare conglomerate’s stock, valued at approximately $923,000. UnitedHealth Group comprises about 0.9% of Meadow Creek Wealth Advisors LLC’s holdings, making the stock its 22nd largest position.

Other institutional investors have also modified their holdings of the company. Robbins Farley acquired a new stake in UnitedHealth Group in the 3rd quarter valued at about $25,000. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group in the fourth quarter valued at approximately $26,000. CGC Financial Services LLC grew its stake in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the last quarter. NewSquare Capital LLC grew its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL acquired a new stake in shares of UnitedHealth Group in the first quarter worth $35,000. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on UNH. Royal Bank of Canada reiterated an “outperform” rating and set a $596.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 29th. Truist Financial reiterated a “buy” rating and set a $610.00 price target on shares of UnitedHealth Group in a research note on Thursday, November 30th. HSBC reiterated a “reduce” rating and set a $480.00 price target (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Piper Sandler cut their price objective on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a report on Wednesday, January 17th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $579.33.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $1.60 during trading on Thursday, reaching $494.70. The company’s stock had a trading volume of 3,805,551 shares, compared to its average volume of 4,097,774. The stock has a 50-day moving average price of $503.10 and a two-hundred day moving average price of $518.61. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a one year low of $445.68 and a one year high of $554.70. The stock has a market capitalization of $456.08 billion, a P/E ratio of 20.70, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, topping the consensus estimate of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. During the same period in the previous year, the business posted $5.34 EPS. The company’s quarterly revenue was up 14.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. UnitedHealth Group’s payout ratio is 31.54%.

Insider Buying and Selling

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.